For a study, researchers investigated moderators of cognitive-behavioral therapy (CBT) treatment effects and outcome predictors at 12-month follow-up in the CODES Trial (N=368), which compared CBT plus standardized medical care (SMC) vs. SMC-alone for dissociative seizures (DS). Investigators used moderator analyses of baseline characteristics to determine who benefited from receiving CBT 12 months after randomization.